Search results
- 28.38Add to watchlist-0.06 (-0.21%)At close:4:02 PM EDTTue. May 14, 202428.42 +0.05 (+0.16%)After hrs:6:54 PM EDTTue. May 14, 2024Nasdaq Real Time Price (USD) · Market closed
- Open28.55High28.68Low28.19
- Mkt Cap160.82BP/E (TTM)N/ADiv & Yield1.68 & 5.91%
- Prev. Close28.4452 Wk. Low25.2052 Wk. High40.37
What analysts are sayingRelated stocks
3,000 shares
- Pfizer Inc. (NYSE:PFE - Get Free Report) Director Scott Gottlieb purchased 3,000 shares of the stock in a transaction dated Friday, December 15th. The stock was acquired at an average cost of $26.47 per share, with a total value of $79,410.00.
People also ask
Will Scott Gottlieb buy Pfizer?
How much money does David Gottlieb make at Pfizer?
Will Dr Gottlieb join Pfizer's board of directors?
Should you buy Pfizer (PFE) if you see insider buying?
May 18, 2023 · Back on May 8, Gottlieb invested $77,005.00 into 2,000 shares of PFE, for a cost per share of $38.50. In trading on Thursday, bargain hunters could buy shares of Pfizer and achieve a cost basis...
- Dividend Channel
Dec 19, 2023 · Pfizer Inc. (NYSE:PFE - Get Free Report) Director Scott Gottlieb acquired 3,000 shares of the firm's stock in a transaction on Friday, December 15th. The stock was purchased at an average price of $26.47 per share, with a total value of $79,410.00.
Mar 16, 2020 · In the last twelve months, the biggest single purchase by an insider was when insider Scott Gottlieb bought US$104k worth of shares at a price of US$34.72 per share.
Dec 21, 2023 · Scott Gottlieb, Director, Pfizer Inc. (PFE), bought 3,000 shares of the company's common stock on 12/15/2023 for a total of 79,401.
Dec 20, 2023 · The Trade: Pfizer Inc. PFE Director Scott Gottlieb bought a total of 3,000 shares at an average price of $26.47. To acquire these shares, it cost around $79,401. What’s Happening: Truist...
- Avi Kapoor
Jul 5, 2019 · Two months after stepping down as the head of the Food and Drug Administration, Scott Gottlieb has quietly taken a seat on the board of Pfizer.
Scott Gottlieb, M.D. Age: 51 years Partner, New Enterprise Associates, Inc.’s Healthcare Investment Team and Resident Fellow of the American Enterprise Institute since 2019.